| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/13/2006 | US20060154314 Using synaptosomal associated protein-25 (SNAP-25) as tool to screen for clostridial toxin protease activity; food safety; detecting food poisoning |
| 07/13/2006 | US20060154313 Human B7 polypeptide B7-H3A |
| 07/13/2006 | US20060154311 Antibody specifically binding to a fragment of a nuclear matrix protein, BLCA-1 or BLCA-4, present only in cancerous bladder cells; drug conjugates; labeled antibodies; diagnostics; antiproliferative agents |
| 07/13/2006 | US20060154310 Detecting the presence of a prostate cancer cell expressing a protein SGP28; immunoassay |
| 07/13/2006 | US20060154307 Receptor assay |
| 07/13/2006 | US20060154296 Pigment protein |
| 07/13/2006 | US20060154294 Interleukin-18 binding proteins, their preparation and use |
| 07/13/2006 | US20060154293 Regulation of human prostasin-like serine protease |
| 07/13/2006 | US20060154291 Reagents and methods useful for detecting diseases of the breast |
| 07/13/2006 | US20060154285 Zebrafish heterotrimer G-protein gamma 2 subunit (GNG2) |
| 07/13/2006 | US20060154277 Compositions and methods for diagnosing or treating psoriasis |
| 07/13/2006 | US20060154258 Card-domain containing polypeptides, encoding nucleic acids, and methods of use |
| 07/13/2006 | US20060154250 Novel compositions and methods in cancer |
| 07/13/2006 | US20060154249 Method and kit for detecting a risk for diabetes or a metabolic syndrome |
| 07/13/2006 | US20060154244 Novel g-protein coupled receptor |
| 07/13/2006 | US20060154243 Antigenic peptides of SARS coronavirus and uses thereof |
| 07/13/2006 | US20060154238 Compounds and methods of early diagnosis of cervical cancer and genital condyloma with hpv, chsp60 tumor suppressor h-ras, k-ras and pten derived peptides modified |
| 07/13/2006 | US20060153884 can be associated with the peptide 111-136 of HARP; cancer treatment |
| 07/13/2006 | US20060153881 P. falciparum erythrocyte binding protein-2 (EBP2) Region II (RII), used to induce an immune response to Plasmodium falciparum merozoites to treat diseases such as malaria |
| 07/13/2006 | US20060153876 Cell membrane translocation of regulated snare inhibitors, compositions therefor, and methods for treatment of disease |
| 07/13/2006 | US20060153875 Novel brachyspira hyodyseteriae vaccine |
| 07/13/2006 | US20060153871 vaccine comprising the virus; immunization; diagnostic method comprising contacting a physiological sample of an animal suspected of containing antiinfluenza virus antibodies with the claimed virus |
| 07/13/2006 | US20060153870 Method for the recovery of non-segmented, nagative-stranded RNA viruses from cDNA |
| 07/13/2006 | US20060153866 Human immunodeficiency virus-1 group O/M envelope polypeptide fusion for use as evaluative tool in diagnosing viral infection |
| 07/13/2006 | US20060153865 Antigenic peptides |
| 07/13/2006 | US20060153864 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 07/13/2006 | US20060153862 Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses |
| 07/13/2006 | US20060153861 BCR-ABL imatinib resistance-associated peptides and methods of use thereof |
| 07/13/2006 | US20060153860 Single chain Fv fragments which bind epidermal growth factor receptors and/or HER2 genes; pharmacokinetics |
| 07/13/2006 | US20060153858 Drug delivery of a liquid comprising an antigen such as tumor-associated antigen directly to an area of high lymphatic drainage or a lymphatic system of the mammal to induce an antigen-specific Cytotoxic T lymphocyte (CTL) response; sustained release |
| 07/13/2006 | US20060153853 Cancers of the breast, prostate, colorectal, lung, thyroid, ovaries, and brain as well as in childhood leukaemias, glioblastomas, and neuroblastomas; Insulin-like Growth Factor Binding Protein (IGFBP) with reduced IGF (Insulin-like Growth Factor) release characteristics |
| 07/13/2006 | US20060153851 CLASP proteins |
| 07/13/2006 | US20060153849 Methods of treatment with an antibody that suppresses growth differentiation factor-14 activity |
| 07/13/2006 | US20060153841 Nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro |
| 07/13/2006 | US20060153836 Using monoclonal antibody specific for kidney injury-molecule-1 (KIM-1) to diagnose, prevent and treat cell proliferative and kidney disorders; immunotherapeutics |
| 07/13/2006 | US20060153833 Anti hepatitis C virus antibody and uses thereof |
| 07/13/2006 | US20060153820 Materials and methods relating to the production and maintenance of cell lines |
| 07/13/2006 | US20060153806 Proteins involved in the regulation of energy homeostasis |
| 07/13/2006 | US20060153805 Viral vectors and the use of the same for gene therapy |
| 07/13/2006 | US20060153802 Mammalian chemokine reagents |
| 07/13/2006 | US20060153800 DNA immunization with recombinase/transposase |
| 07/13/2006 | US20060153791 Mixture of protein polymer and active materials |
| 07/13/2006 | CA2594276A1 Neutralizing epitope-based growth enhancing vaccine |
| 07/13/2006 | CA2594233A1 Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 ) |
| 07/13/2006 | CA2594023A1 Igf-i fusion polypeptides and therapeutic uses thereof |
| 07/13/2006 | CA2593682A1 Glycopegylated granulocyte colony stimulating factor |
| 07/13/2006 | CA2592943A1 Use of il-22 for the treatment of conditions of metabolic disorders |
| 07/13/2006 | CA2592756A1 Compositions for immunizing against mycobacterium |
| 07/13/2006 | CA2592704A1 Nucleotide sequences encoding ramosa3 and sister of ramosa3 and methods of use for same |
| 07/13/2006 | CA2592292A1 Sustained delivery of pdgf using self-assembling peptide nanofibers |
| 07/13/2006 | CA2591956A1 Probe for detecting nucleic acids |
| 07/13/2006 | CA2590462A1 Methods for expression and purification of recombinant human growth hormone |
| 07/13/2006 | CA2589060A1 Hemopexin-like structure as polypeptide-scaffold |
| 07/13/2006 | CA2588871A1 Gram positive bacterial cells comprising a disrupted flagellin gene, flagellin-based fusion proteins and use in removal of metal ions from a liquid |
| 07/13/2006 | CA2585733A1 Adiponectin variants |
| 07/13/2006 | CA2575248A1 Antibody vaccine conjugates and uses therefor |
| 07/13/2006 | CA2566507A1 Prophylactic and therapeutic uses of fgf-20 in radiation protection |
| 07/13/2006 | CA2563656A1 Enriched pag-55 fraction and methods for early detection of pregnancy in ungulate animals |
| 07/12/2006 | EP1679377A1 Feline immunodeficiency virus vaccine |
| 07/12/2006 | EP1679376A2 Recombinant adenovirus comprising a chimeric penton base protein |
| 07/12/2006 | EP1679372A1 Novel plexin polypeptide, dna encoding the same and use thereof |
| 07/12/2006 | EP1679320A1 Derivatives of breast cancer antigen her-2 for therapeutical use |
| 07/12/2006 | EP1679319A1 Methods for Preventing and Treating Alzheimer´s Disease (AD) |
| 07/12/2006 | EP1679081A2 Therapeutic application of cephaibols |
| 07/12/2006 | EP1679080A2 Prevention and treatment of amyloidogenic disease |
| 07/12/2006 | EP1678504A1 Assay for diabetes |
| 07/12/2006 | EP1678497A2 Methods and compositions for modulating apoptosis |
| 07/12/2006 | EP1678325A2 Novel splice variants of human dkkl1 |
| 07/12/2006 | EP1678316A2 Campylobacter polypeptides and methods of use |
| 07/12/2006 | EP1678315A2 Engineered zinc finger proteins for regulation of gene expression |
| 07/12/2006 | EP1678311A2 Retroviral and lentiviral vectors |
| 07/12/2006 | EP1678310A1 Axmi-010, a delta-endotoxin gene and methods for its use |
| 07/12/2006 | EP1678305A2 Protozoan strains of reduced virulence and use thereof |
| 07/12/2006 | EP1678304A1 Cellular model of tauopathies for lead identification and drug discovery |
| 07/12/2006 | EP1678298A2 Expression of dominant negative transmembrane receptors in the milk of transgenic animals |
| 07/12/2006 | EP1678294A1 Vaccine for periodontal disease |
| 07/12/2006 | EP1678292A2 Improved mva vaccines |
| 07/12/2006 | EP1678291A2 Isolated nucleotide sequences responsible for the tomato high pigment-1 mutant phenotypes (hp-1 and hp-1w) and uses thereof |
| 07/12/2006 | EP1678207A1 Regulation of matrix metalloproteinases by psp94 family members |
| 07/12/2006 | EP1678206A2 Oligomeric complexe formation of recombinant multi subunit chimeric polypeptides |
| 07/12/2006 | EP1678205A1 Clq RELATED PROTEIN |
| 07/12/2006 | EP1678204A1 Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof |
| 07/12/2006 | EP1678203A2 Multiepitope polypeptides for cancer immunotherapy |
| 07/12/2006 | EP1678202A1 Hcv ns3-ns4a protease resistance mutants |
| 07/12/2006 | EP1678200A2 A method of modulating cell survival, differentiation and/or synaptic plasticity |
| 07/12/2006 | EP1678197A2 Methods and compositions for pdgf-c activation and inhibition |
| 07/12/2006 | EP1678195A2 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 07/12/2006 | EP1677885A2 Fractal-forming alkylketene dimers for integral membrane protein crystal growth |
| 07/12/2006 | EP1677842A2 Fibres embedded in a glassy protein |
| 07/12/2006 | EP1677833A2 In vivo gene therapy of parkinson's disease |
| 07/12/2006 | EP1677825A2 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom |
| 07/12/2006 | EP1677820A1 Colorectal cancer antigen |
| 07/12/2006 | EP1677819A1 Long-acting molecules in sustained release formulations |
| 07/12/2006 | EP1677815A1 Selective inhibition of nf-kappab activation by peptides designed to disrupt nemo oligomerization. |
| 07/12/2006 | EP1677813A1 Angiogenic peptides and uses thereof |
| 07/12/2006 | EP1677737A2 Treatment of demyelinating autoimmune disease with modified ordered peptides |
| 07/12/2006 | EP1677735A2 Methods and compositions for modulating adipocyte function |
| 07/12/2006 | EP1677734A2 Cystatin c as an antagonist of tgf-b and methods related thereto |
| 07/12/2006 | EP1677665A2 Determination of ions using ion-sensitive enzymes |
| 07/12/2006 | EP1625161A4 A synthetic bioelastomer |